GAVI facts and figures

in page functions

Statistics measuring the GAVI Alliance's impact on global immunisation

Every year, academics, journalists, teachers and students ask for statistics detailing GAVI's results since the Alliance was established in 2000. Sourcing the GAVI Secretariat and members of the Alliance, including WHO, UNICEF and civil society organisations, these key facts and figures list GAVI's achievements to date as well as demonstrating the Alliance's catalytic role within global immunisation.

50

GAVI has helped strengthen health and immunisation systems in more than 50 countries.

Source: GAVI Alliance

70%

70% of cervical cancer cases can be prevented with human papillomavirus vaccines.

Source: World Health Organization

60

In 2012, almost 60 countries were co-financing new vaccines supplied by GAVI.

Source: GAVI Alliance

10 million

It is estimated that over 10 million children have been immunised against pneumococcal disease with GAVI support by the end of 2012.

Source: WHO Department of Immunisation, Vaccines and Biologicals’ estimates and projections, as of October 2012

5.5 million

More than 5.5 million deaths averted from hepatitis B, Haemophilus influenzae type B, measles, pertussis, pneumococcal disease, polio, rotavirus diarrhoea and yellow fever since GAVI's launch in 2000.

Source: WHO Department of Immunisation, Vaccines and Biologicals’ estimates and projections, as of October 2012

370 million

Since its launch in 2000, GAVI support has contributed to the immunisation of an additional 370 million children in the world's poorest countries.

Source: WHO-UNICEF 2012

+245,000,000

GAVI support will assist countries to immunise a further 245 million children from 2011 to 2015.

Source: GAVI Alliance

73 countries

GAVI supports the 73 poorest countries in the world.

Source: GAVI Alliance

US$ 8.4 billion

By 30 April 2013, GAVI had committed US$ 8.4 billion in programme support until 2016 to the world’s poorest countries.

Source: GAVI Alliance, 30 April 2013

4 million

GAVI's support for vaccines through to 2015 will contribute to averting an additional four million future deaths.

Source: WHO Department of Immunisation, Vaccines and Biologicals’ estimates and projections, as of October 2012

39%

Over the course of a decade, the weighted average price of pentavalent vaccine dropped by 39% from US$ 3.56 in 2003 to US$ 2.17 per dose in 2012, with a lowest ever price of US$ 1.19 per dose from one supplier in 2013.

Source: GAVI Alliance 2013

1 in 5

1 in 5 of all children who die before the age of five lose their lives to vaccine-preventable diseases.

Source: WHO Department of Immunisation, Vaccines and Biologicals’ estimates and projections, as of October 2012

5 -> 10

2001: 5 vaccine suppliers to GAVI (1 in an emerging market) | 2011: 10 vaccine suppliers to GAVI (5 in emerging markets)

Source: UNICEF Supply Division, 2012

22 million

Over 22 million infants remain unimmunised in the world each year.

Source: WHO/UNICEF

close icon

modal window here